Gene Editing in the Mouse Womb Corrects Inherited Lung Disease in Mouse Fetuses (1 of 1) (IMAGE)
Caption
The scientists used CRISPR-Cas9 to target pulmonary epithelial cells (blue), and observed cells were successfully gene-edited (green). This material relates to a paper that appeared in the Apr. 17, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by y D. Alapati at Nemours Alfred I duPont Hospital for Children in Wilmington, DE; and colleagues was titled, "In utero gene editing for monogenic lung disease."
Credit
D. Alapati<i> et al., Science Translational Medicine </i>(2019)
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content